Cancer: Difference between revisions

Revision as of 12:28, 30 November 2010

Cancer is a class of diseases marked by uncontrolled cellular growth resulting in intrusion on and destruction of adjacent tissues, while often spreading to other locations in the body via the lymphatic or circulatory systems.

Articles in Proteopedia concerning Cancer include:

To view Cancer related proteins which are Structure Index entries see:

To view automatically seeded indices concerning Cancer See:

FDA Approved Treatments for CancerFDA Approved Treatments for Cancer

EGFR InhibitorEGFR Inhibitor

Herceptin - Generic: Trastuzumab
Iressa - Generic: Gefitinib
Tarceva - Generic: Erlotinib

VEGF InhibitorVEGF Inhibitor

Avastin - Generic: Bevacizumab
Tykerb - Generic: Lapatinib
Sutent - Generic: Sunitinib
Nexavar - Generic: Sorafenib

To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner, Wayne Decatur, Jaime Prilusky, Alexander Berchansky, Gonzalo Garcia-Martin

@@ Line 65: / Line 65: @@
 <br />
-To View FDA Approved Treatments for [[Cancer]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]]
+====FDA Approved Treatments for [[Cancer]]====
+<table style="background: cellspacing="5px"  cellpadding="10px" width="100%">
+<tr>
+<td style="width:25%; vertical-align:top;border-width:1px; border-style:inset">
+=====[[EGFR]] Inhibitor=====
+* Herceptin - Generic: Trastuzumab
+* [[Iressa]] - Generic: Gefitinib
+* [[Tarceva]] - Generic: Erlotinib
+=====[[VEGF]] Inhibitor=====
+* Avastin - Generic: Bevacizumab
+* Tykerb - Generic: Lapatinib
+* Sutent - Generic: Sunitinib
+* Nexavar - Generic: Sorafenib
+</td>
+</tr>
+</table>
 To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]]